|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01061 ESSEX BIO-TECH
Nominal 
5.390 -0.010 (-0.185%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 876,535 | 5.793% | 1,669,817 | 1,736,972 | 1,317,711 | 1,637,659 |
| Cost of Sales | (97,932) | 9.126% | (171,154) | (174,943) | (128,382) | (241,893) |
| Gross Profit | 778,603 | 5.388% | 1,498,663 | 1,562,029 | 1,189,329 | 1,395,767 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (161) | -91.744% | (2,911) | (1,641) | (194) | 0 | |
| Profit / (Loss) before Taxation | 203,573 | 3.138% | 375,500 | 346,014 | 260,343 | 394,457 | |
| Taxation | (40,172) | 0.581% | (68,278) | (70,755) | (34,931) | (48,489) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 163,401 | 3.786% | 307,222 | 275,260 | 225,411 | 345,968 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (2,621) | -23.138% | (5,359) | (1,131) | 2,594 | (636) |
| Depreciation & Amortisation | 28,457 | 7.466% | 55,873 | 59,876 | 41,913 | 32,971 |
| Directors' Emoluments | -- | -- | 8,277 | 8,331 | 8,594 | 9,616 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 28.820 | 3.893% | 54.140 | 48.270 | 39.270 | 60.000 |
| DPS (cts) | 7.000 | -- | 12.000 | 9.000 | 6.500 | 9.500 |
| Dividend Payout Ratio (%) | 24.289% | -- | 22.165% | 18.645% | 16.552% | 15.833% |
| Cash flow per share ($) | -- | -- | 0.649 | 0.595 | 0.667 | 0.710 |
| NBV per share ($) | 4.010 | -- | 3.745 | 3.389 | 3.029 | 3.013 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 163,401 |
| %Change | 3.786% |
| EPS / (LPS) | HKD 0.288 |
| NBV Per Share ($) | HKD 4.010 |